In PsO-3, subjects who were originally on SKYRIZI and had sPGA 0 or 1 at Week 28 were re-randomized to continue SKYRIZI every 12 weeks or withdrawal of therapy. At Week 52, 87% …

FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for …

1 INDICATIONS AND USAGE 1.1 Plaque Psoriasis SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or …

Afterwards, you will receive or inject yourself a different dose of Skyrizi as maintenance therapy by an injection under your skin (subcutaneous injection) using an on-body injector with pre …

SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet …

Sep 16, 2025 · Skyrizi Injection package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using …

Sep 3, 2025 · AbbVie Inc.: SKYRIZI is an interleukin-23 antagonist indicated for the treatment of: moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or …

Oct 21, 2024 · THERAPY ADMINISTRATION Skyrizi Intravenous Infusion For Crohn’s Disease: Dose: 600mg IV infusion over 1 hour Route: IV For Ulcerative Colitis: Dose: 1200mg IV …

Jun 26, 2019 · Overview Skyrizi is a medicine used to treat adults with: moderate-to-severe plaque psoriasis (a disease causing red, scaly patches on the skin) who require systemic …